Clinical Trial Update: Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents [Phase 4]

View source ↗

Summary

Phase 4 multicenter registry evaluating hybrid coronary artery revascularization (surgical bypass plus PCI) using everolimus-eluting metallic stents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting metallic stent (everolimus-eluting stent)

Snippet

Sponsor: Teikyo University | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN